You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

~ Buy the TRILIPIX (choline fenofibrate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR TRILIPIX

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for TRILIPIX

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00300430 ↗	Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.	Completed	Abbott	Phase 3	2006-09-01	The primary purpose of this study is to test the safety and the effects of using an investigational drug regimen; once daily ABT-335 (Investigational drug) administered in combination with once daily atorvastatin calcium, rosuvastatin calcium or simvastatin in patients with abnormal lipid levels in the blood.
NCT00639158 ↗	Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood	Completed	Abbott	Phase 3	2008-02-01	The primary purpose of this study is to compare the safety and efficacy of ABT-335 (investigational drug) coadministered with atorvastatin and ezetimibe to atorvastatin coadministered with ezetimibe in subjects with abnormal lipid (fat) levels in the blood.
NCT00813527 ↗	Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels	Completed	Takeda	Phase 2	2006-02-01	The purpose of this study is to compare changes in cholesterol levels in patients with elevated blood cholesterol with administration of lapaquistat acetate, once daily (QD), and fenofibrate.
NCT00839293 ↗	Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules	Completed	Abbott	Phase 1	2009-02-01	The purpose of this study is to evaluate the safety and compare the bioavailability of fenofibric acid from 2 different dosage strengths of ABT-335.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for TRILIPIX

Condition Name

Chart
Table

Condition Name for TRILIPIX
Intervention	Trials
Coronary Heart Disease	2
Dyslipidemia	2
Healthy	2
Mixed Dyslipidemia	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for TRILIPIX
Intervention	Trials
Coronary Artery Disease	3
Myocardial Ischemia	3
Dyslipidemias	3
Heart Diseases	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for TRILIPIX

Trials by Country

Map
Table

Trials by Country for TRILIPIX
Location	Trials
United States	61
Canada	2
Korea, Republic of	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for TRILIPIX
Location	Trials
Illinois	4
Georgia	3
California	3
South Carolina	3
Missouri	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for TRILIPIX

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for TRILIPIX
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	3
Phase 2	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for TRILIPIX
Clinical Trial Phase	Trials
Completed	7
Terminated	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TRILIPIX

Sponsor Name

Chart
Table

Sponsor Name for TRILIPIX
Sponsor	Trials
Abbott	4
Takeda	1
University of Utah	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for TRILIPIX
Sponsor	Trials
Industry	6
Other	4
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.